The long range goal of this project is to determine the mechanisms by which cationic amphiphilic drugs (amiodarone) and aminoglycosides (gentamicin) cause phospholipid storage in the lysosomes of their target tissues leading ultimately to cell damage. The project stresses evaluation of drug-induced alterations in the intracellular processing of complex lipids. A newly-discovered class of intracellular inhibitor proteins will be characterized and the role of these protein(s) in drug-induced lipidosis will be assessed. The proposed studies have health-related implications since the drugs are used by large numbers of patients and the studies are relevant to side effects suffered by users which include: (1) nephrotoxicity (aminoglycosides) and (2) hepatic and pulmonary lipidosis and fibrosis (amiodarone).
The specific aims are to determine the biochemical basis for the phospholipidosis produced by cationic amphiphiles such as amiodarone (specific aim 1) and aminoglycosides (specific aim 2). The problem will be approached by determining the intracellular distribution of these agents in liver, lung and kidney and measuring their intralysosomal concentration using our recently published method. Lysosomal phospholipases A and C will be purified and inhibitor studies carried out to determine the mechanism(s). Drug binding to substrate will also be measured and taken into account in determination of the mechanism(s) involved in inhibition of the lipolytic enzymes. Since fibrosis is a serious clinical side effect of amiodarone studies will be undertaken with amiodarone to evaluate the relationship of phospholipidosis to fibrosis and collagen metabolism in the liver and lung of rats in vivo and in cultured fibroblasts. The third specific aim regards the characterization of the intracellular protein inhibitors of phospholipase which we recently identified during the purification of kidney phospholipase A1. The inhibitory proteins will be purified based on their ability to inhibit pure phospholipases and their involvement in drug induced lipidosis and aminoglycoside nephrotoxicity will be investigated in vitro and in vivo. The effect of glucocorticoids on these proteins will be determined since lysosomal """"""""stabilization"""""""" by glucocorticoids might involve the cortisol-dependent synthesis of phospholipase inhibitors similar to that described for """"""""lipomodulin"""""""", """"""""macrocortin"""""""" and """"""""renocortin"""""""".

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM024979-13
Application #
3272711
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1978-04-01
Project End
1991-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
13
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Beadle, J R; Kini, G D; Aldern, K A et al. (1998) Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cells. Antivir Chem Chemother 9:33-40
Hostetler, K Y; Beadle, J R; Kini, G D et al. (1997) Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro. Biochem Pharmacol 53:1815-22
Taskintuna, I; Banker, A S; Flores-Aguilar, M et al. (1997) Evaluation of a novel lipid prodrug for intraocular drug delivery: effect of acyclovir diphosphate dimyristoylglycerol in a rabbit model with herpes simplex virus-1 retinitis. Retina 17:57-64
Kini, G D; Beadle, J R; Xie, H et al. (1997) Alkoxy propane prodrugs of foscarnet: effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV. Antiviral Res 36:43-53
Schlame, M; Hostetler, K Y (1997) Cardiolipin synthase from mammalian mitochondria. Biochim Biophys Acta 1348:207-13
Kini, G D; Hostetler, S E; Beadle, J R et al. (1997) Synthesis and antiviral activity of 1-O-octadecyl-2-O-alkyl-sn-glycero-3-foscarnet conjugates in human cytomegalovirus-infected cells. Antiviral Res 36:115-24
Korba, B A; Xie, H; Wright, K N et al. (1996) Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo. Hepatology 23:958-63
Xie, H; Voronkov, M; Liotta, D C et al. (1995) Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells. Antiviral Res 28:113-20
Shakiba, S; Freeman, W R; Flores-Aguilar, M et al. (1995) Antiviral effect in human cytomegalovirus-infected cells, pharmacokinetics, and intravitreal toxicology in rabbits of acyclovir diphosphate dimyristoylglycerol. Antimicrob Agents Chemother 39:1383-5
Hostetler, K Y; Richman, D D; Sridhar, C N et al. (1994) Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice. Antimicrob Agents Chemother 38:2792-7

Showing the most recent 10 out of 38 publications